Individuals with prostate cancer who continue to smoke may face nearly twice the risk of the cancer recurring, according to new research.
The study included more than 7,000 participants who had undergone surgery to remove their prostate following a cancer diagnosis. They were followed for an average of 28 months. About two thirds of the patients were either current or former smokers.
Former smokers who had quit within the last 10 years also had a significantly higher risk of cancer recurrence when compared to those who had never smoked.
The researchers–an international group of scientists and clinicians–presented the findings late last month at the European Association of Urology conference, in Madrid.
The findings suggest that identifying patients who smoke and connecting them to cessation services may improve long term outcomes.